Ubs Group Ag Oramed Pharmaceuticals Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Ubs Group Ag holds 9,291 shares of ORMP stock, worth $22,391. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,291

Previous 4,649 99.85%

Holding current value

$22,391

Previous $13,000 76.92%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.07 - $2.83 $9,608 - $13,136	4,642 Added 99.85%	9,291 $23,000
Q1 2024 May 13, 2024	SELL	$2.18 - $3.58 $909 - $1,492	-417 Reduced 8.23%	4,649 $13,000
Q4 2023 Feb 09, 2024	SELL	$1.71 - $2.57 $1,949 - $2,929	-1,140 Reduced 18.37%	5,066 $11,000
Q3 2023 Nov 09, 2023	BUY	$2.51 - $3.55 $160 - $227	64 Added 1.04%	6,206 $16,000
Q2 2023 Aug 11, 2023	SELL	$2.12 - $4.47 $197,143 - $415,674	-92,992 Reduced 93.8%	6,142 $21,000
Q1 2023 May 12, 2023	BUY	$1.93 - $13.1 $170,654 - $1.16 Million	88,422 Added 825.45%	99,134 $216,000
Q4 2022 Feb 08, 2023	BUY	$5.88 - $12.03 $13,506 - $27,632	2,297 Added 27.3%	10,712 $128,000
Q3 2022 Nov 10, 2022	BUY	$4.6 - $9.91 $17,774 - $38,292	3,864 Added 84.9%	8,415 $54,000
Q2 2022 Aug 10, 2022	BUY	$3.72 - $9.0 $5,654 - $13,680	1,520 Added 50.15%	4,551 $21,000
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $87,182 - $147,859	-10,645 Reduced 77.84%	3,031 $26,000
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $162,275 - $371,934	12,502 Added 1064.91%	13,676 $195,000
Q3 2021 Nov 15, 2021	SELL	$12.13 - $23.82 $309,399 - $607,576	-25,507 Reduced 95.6%	1,174 $26,000
Q2 2021 Aug 13, 2021	BUY	$8.34 - $14.59 $207,649 - $363,261	24,898 Added 1396.41%	26,681 $357,000
Q1 2021 May 12, 2021	BUY	$4.22 - $11.33 $6,967 - $18,705	1,651 Added 1250.76%	1,783 $18,000
Q4 2020 Feb 11, 2021	SELL	$2.48 - $4.64 $22,882 - $42,813	-9,227 Reduced 98.59%	132 $1,000
Q3 2020 Nov 12, 2020	BUY	$2.58 - $4.16 $13,748 - $22,168	5,329 Added 132.23%	9,359 $24,000
Q2 2020 Jul 31, 2020	SELL	$2.87 - $4.12 $10,311 - $14,803	-3,593 Reduced 47.13%	4,030 $15,000
Q1 2020 May 01, 2020	BUY	$2.6 - $5.5 $19,299 - $40,826	7,423 Added 3711.5%	7,623 $24,000
Q4 2019 Feb 14, 2020	SELL	$2.43 - $5.74 $3,727 - $8,805	-1,534 Reduced 88.47%	200 $1,000
Q3 2019 Nov 14, 2019	SELL	$2.88 - $3.96 $544 - $748	-189 Reduced 9.83%	1,734 $6,000
Q2 2019 Aug 14, 2019	BUY	$2.88 - $4.36 $1,995 - $3,021	693 Added 56.34%	1,923 $7,000
Q1 2019 May 14, 2019	SELL	$2.95 - $3.64 $4,622 - $5,703	-1,567 Reduced 56.02%	1,230 $5,000
Q4 2018 Feb 14, 2019	SELL	$3.0 - $4.94 $1,188 - $1,956	-396 Reduced 12.4%	2,797 $9,000
Q3 2018 Nov 14, 2018	SELL	$4.64 - $7.11 $23,074 - $35,358	-4,973 Reduced 60.9%	3,193 $16,000
Q2 2018 Aug 14, 2018	SELL	$6.29 - $8.22 $4,088 - $5,343	-650 Reduced 7.37%	8,166 $61,000
Q1 2018 May 15, 2018	SELL	$6.51 - $9.14 $56,070 - $78,722	-8,613 Reduced 49.42%	8,816 $57,000
Q4 2017 Feb 14, 2018	BUY	$7.95 - $11.15 $118,812 - $166,636	14,945 Added 601.65%	17,429 $157,000
Q3 2017 Nov 14, 2017	BUY	$7.74 - $10.78 $16,904 - $23,543	2,184 Added 728.0%	2,484 $25,000
Q2 2017 Aug 14, 2017	SELL	N/A	-83 Reduced 21.67%	300 $2,000
Q1 2017 Nov 14, 2017	BUY	N/A	383	383 $3,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

6.37M

Call Options Held

Put Options Held

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $93.6M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account